Dr. Armstrong
Dr. Armstrong
longer months received route survival time via women
In our trial, women who received part of their chemotherapy via an IP route had a median survival time of 16 months longer than women who received only IV chemotherapy.
major question step
I think it's a major step forward. There's no question about it.
advanced bulk cancer data firm remove showing successful surgery women
But now we have firm data showing we should use (it) in most women with advanced ovarian cancer who have had successful surgery to remove the bulk of their tumor.
advanced date longest reported survival
This is the longest survival reported to date for advanced ovarian cancer.